Balance Sheet Data
Acorda Therapeutics Inc (ACOR)
$6.7
0.33 (+5.18%)
Year A/P | 2013 Actual | 2014 Actual | 2015 Actual | 2016 Actual | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Projected | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected |
| Total Cash | 273.93 | 307.62 | 353.30 | 158.54 | 307.07 | 445.55 | 125.84 | 125.88 | 122.04 | 118.31 | 114.70 | 111.20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||||
| Account Receivables | 30.78 | 32.21 | 31.47 | 52.24 | 81.40 | 23.43 | 22.08 | 17.03 | 16.51 | 16.00 | 15.52 | 15.04 |
| Account Receivables (%) | ||||||||||||
| Inventories | 26.17 | 26.84 | 36.48 | 43.13 | 37.50 | 29.01 | 25.22 | 14.87 | 14.42 | 13.98 | 13.55 | 13.14 |
| Inventories (%) | ||||||||||||
| Accounts Payable | 17.98 | 20.29 | 17.07 | 29.91 | 31.07 | 49.37 | 26.84 | 13.14 | 12.74 | 12.35 | 11.98 | 11.61 |
| Accounts Payable (%) | ||||||||||||
| Capital Expenditure | -14.66 | -483.93 | -7.07 | -273.54 | -14.38 | -33.91 | -90.43 | -62.78 | -60.87 | -59.01 | -57.21 | -55.46 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.